Simultaneous resection of the primary tumour and liver metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: protocol of a multicentre, prospective, randomised phase III control trial (CSPAC-1)
Introduction Approximately 50% of pancreatic ductal adenocarcinoma (PDAC) patients are diagnosed with distant metastasis, especially liver metastasis. The current standard treatment for these stage IV patients is palliative chemotherapy. There is increasing agreement that synchronous PDAC and liver...
Saved in:
| Main Authors: | Jin Xu, Si Shi, Jie Hua, Miaoyan Wei, Xianjun Yu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/9/12/e033452.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety of simultaneous colon and liver resection for colorectal liver metastases
by: Stojanović Miroslav, et al.
Published: (2008-01-01) -
The Impact of Simultaneous Liver Resection for Occult Liver Metastases of Pancreatic Adenocarcinoma
by: F. Klein, et al.
Published: (2012-01-01) -
Efficacy and safety of simultaneous resection versus staged resection for initially resectable rectal cancer with synchronous liver metastases
by: Zhekun HUANG, et al.
Published: (2025-06-01) -
Modern Treatment of Skeletal Metastases: Multidisciplinarity and the Concept of Oligometastasis in the Recent Literature
by: Giulia Trovarelli, et al.
Published: (2025-04-01) -
Outcomes of simultaneous resection for colorectal liver metastases: A nationwide cohort study (2005–2022)
by: J.H. Angelsen, et al.
Published: (2025-09-01)